Upgrade to SI Premium - Free Trial

Goldman Sachs Assumes Arrowhead Pharma (ARWR) at Neutral

September 24, 2026 5:00 AM
(Updated - September 24, 2026 5:33 AM EDT)

Goldman Sachs analyst Andrea Newkirk assumes coverage on Arrowhead Pharma (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage